This document is page 29 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019, analyzing the CBD tincture market. It presents data on price segmentation among competitors (such as Lord Jones and Lazarus) and consumer demographics regarding tincture usage. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024845', indicating it was obtained during a House Oversight Committee investigation, likely as part of a larger cache of documents from a financial institution, though the content itself is strictly market research.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Email address listed in the distribution watermark: michael.cella@cowen.com
|
| Name | Type | Context |
|---|---|---|
| Cowen |
Financial services firm producing the report (Cowen and Company)
|
|
| House Oversight Committee |
Implied by Bates stamp 'HOUSE_OVERSIGHT_024845'
|
|
| Lord Jones |
CBD company listed in price comparison
|
|
| Lazarus |
CBD company listed in price comparison
|
|
| Medix CBD |
CBD company listed in price comparison
|
|
| Diamond CBD |
CBD company listed in price comparison
|
|
| Green Roads |
CBD company listed in price comparison
|
|
| Charlotte's Web |
CBD company listed in price comparison
|
|
| Curaleaf Hemp |
CBD company listed in price comparison
|
"Tinctures are the market leading form factor within CBD"Source
"Lord Jones leads the pack on premium pricing, with its tincture priced at $0.24 per mg of CBD."Source
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."Source
Complete text extracted from the document (2,375 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document